Myzilra Tablets Approved for Contraception

Qualitest and Endo announced that the FDA has approved Myzilra (levonorgestrel and ethinyl estradiol tablets) for use as an oral hormonal contraceptive. Myzilra is a 28-day triphasic regimen that contains levonorgestrel and ethinyl estradiol tablets in three dosage-strength combinations: 0.05mg/0.03mg, 0.075mg/0.04mg, 0.125mg/0.03mg.

For more information call (800) 462-ENDO or visit